Publicacións en colaboración con investigadores/as de Heidelberg University (2)

2013

  1. PARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer

    Journal of Clinical Oncology, Vol. 31, Núm. 23, pp. 2895-2902

2012

  1. Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): A double-blind, phase 3, randomised controlled trial

    The Lancet Oncology, Vol. 13, Núm. 3, pp. 247-255